Kriti Nutrients Ltd

  • BSE Code : 533210
  • NSE Symbol : KRITINUT
  • ISIN : INE798K01010
  • Industry :SOLVENT EXTRACTION

up-arrow 73.34 -1.28(-1.72%)

Open Price ()

76.90

Prev. Close ()

74.62

Volume (No’s)

45,440

Market Cap ()

367.46

Low Price ()

71.00

High Price ()

76.90

 

Book Closure

From Date To Date Announcement
31-Mar-2026 NA Approval and Payment of Interim Dividend of Rs. 3/- (i.e.300%) on the 5,01,03,520 Equity Shares of Re.1/- each for the Financial Year 2025-26. Declaration of Interim dividend @ Rs. 3.00 (300%) per equity share, to celebrate the 3 decades of Kriti Oil Brand, subject to deduction of tax at source, if any, to be paid to those Members whose names appear in the Register of Members of the Company as on Thursday,13' November, 2025 being the Record Date, for the purpose of payment of dividend.
20-Mar-2026 NA Intimation and Submission of Notice of 1/2025-26 EGM of the Company scheduled to be held on Friday,20th March,2026. Announcement regarding providing remote E-Voting Facility for the 1/2025-26 EGM scheduled to be held on Friday,20th March,2026. (As Per BSE Announcement Dated on 26.02.2026) Submission of Proceeding of an Extraordinary General Meeting of the Company held 20th March, 2026 (As Per BSE Announcement Dated on:20.03.2026) Declaration of Results of Remote E-Voting & E-Voting at 01/2025-26 EGM held on 20/03/2026. (As per BSE announcement dated on :23.03.2026). Submission of the Minutes of the 1/2025-26 Extraordinary General Meeting of the Company held on Friday, 20th March, 2026. (As per BSE announcement dated on :09.04.2026)
05-Feb-2026 NA Kriti Nutrients Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve the following businesses along with other routine businesses: 1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended 31st December2025; 2. To take on record the Limited Review Report by the Auditors for the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended 31st December2025; 3. Other general business as may be transacted by the Board. Outcome of the 04/2025-26 Meeting of Board of Directors held on Thursday, 5th February, 2026 at the Corporate Office of the Company as per Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. (As per BSE announcement dated on : 05.02.2026)
13-Nov-2025 NA Intimation of record date for payment of Interim Dividend
13-Nov-2025 NA 300% Special Dividend

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew